ClinicalTrials.gg
CompletedNCT07317128Updated May 13, 2026Results posted

Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity

An interventional study of Test Dentifrice and Colgate Sensitive ProRelief in Dentin Sensitivity, sponsored by HALEON. Completed at 1 site in China. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-13.

Sponsored by HALEON · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 12 years 10 months after the study started (first participant enrolled Jan 2013, registered Dec 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 21 studies in Dentin Sensitivity by HALEON — 3 open to participants now, 4 under way, none of them phase 3. Dentin Sensitivity · HALEON.

Enrollment
13th of 20
120 · median 185
Started
2013
with 1 other
No phase
18 of 21
2 open now
Registered
16th of 21
by date

Among the 21 studies in Dentin Sensitivity by HALEON, this one is the 13th largest by enrollment of the 20 interventional ones that give a count, is one of 2 that started in 2013, is one of 18 with no phase, and was the 16th registered.

Dentin Sensitivity

290 studies on the registry are indexed under Dentin Sensitivity; 47 are open to participants now.

Browse Dentin Sensitivity studies →

Open to participants now

3 of the 21 studies in Dentin Sensitivity by HALEON are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Who these studies take

Of the 18 Dentin Sensitivity studies recruiting now, 6 (33%) set no upper age limit and 11 (61%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Dentin Sensitivity by HALEON, or all of them as a file.
02

Study summary

The purpose of this study is to compare the clinical efficacy of test fluoride dentifrice in reducing Dentin Hypersensitivity (DH) with that of a standard fluoride dentifrice, as measured by evaporative air sensitivity after 12 weeks twice daily brushing.

Read the detailed description

A randomized, examiner blind, three treatment arm, parallel group design with a treatment period of 12 weeks. Approximately 275 participants will be screened to ensure that approximately 120 participants to be randomized (approximately 40 to each treatment group) and at least 114 participants to complete the study (approximately 38 per treatment group).

03

Conditions studied

  • Dentin Sensitivity

Browse trials for

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant demonstrates understanding of the study and is willing to participate as evidenced by voluntary written and has received a signed and dated copy of the informed consent form.
  • Participant is 18 to 60 years of age.
  • Participant understands and is willing, able and likely to comply all study procedures and restrictions.
  • Participant with good general and mental health, in the opinion of the investigator or medically qualified designee:

    1. No and relevant abnormalities of medical history or physical /oral examination.
    2. Absence of any condition that would impact on the participant's safety or wellbeing or affect the participant's ability to understand and follow study procedures and requirements.
  • Self-reported history of DH lasting more than 6 months but not more than 10 years and minimum of 20 natural teeth.

Exclusion criteria

Exclusion Criteria:

  • Female participant who is known to be pregnant or who is intending to become pregnant over the duration of the study.
  • Female participant who is breast-feeding.
  • Participant with known or suspected intolerance or to the study materials (or closely related compounds) or any of their stated ingredients.
  • Participation is in another clinical study or receipt of an drug within 30 days prior to the screening visit.
  • Participant who has had tooth desensitizing treatment within 8 weeks of Screening visit (professional sensitivity treatments and non-dentifrice sensitivity treatments).
  • Participant who had previously participated in this study.
  • Participant with a recent history (within the last year) of alcohol or other substance abuse.
  • Participant who is an employee of the sponsor or the study site or members of their immediate family.
  • Participant with presence of chronic debilitating disease which, in the opinion of the investigator, could affect study outcomes.
  • Participant with any condition or daily doses of a medication which, in the opinion of the investigator, is causing xerostomia.
  • Participant with dental prophylaxis within 4 weeks of screening.
  • Participant with tongue or lip piercing or presence of dental implants.
  • Participant with gross periodontal disease, treatment of periodontal disease (including surgery) within 12 months of screening, scaling or root planning within 3 months of screening.
  • Participant who did teeth bleaching within 8 weeks of screening.
  • Participant with Specific Dentition Exclusions for Test teeth.

    1. Tooth with evidence of current or recent caries, or reported treatment of decay in 12 months of screening.
    2. Tooth with exposed dentine but with deep, defective or facial restorations, teeth used as abutments for fixed or removable partial dentures, teeth with full crowns or veneers, orthodontic bands or cracked enamel. Sensitive teeth with contributing aetiologies other than erosion, abrasion or recession of exposed dentine.
    3. Sensitive teeth are not expected, in the opinion of the investigator, to respond to treatment with an over-the-counter dentifrice.
  • Participant who has used product of a sensitivity dentifrice within 8 weeks of screening.
  • Participant who had daily doses of a medication or traditional herbal ingredients or treatments which, in the opinion of the investigator, could interfere with the perception of pain. Examples of such medications include analgesics, anticonvulsants, antihistamines that cause marked or moderate sedation, sedatives, tranquilizers, mood-altering and anti-inflammatory drugs. Examples of herbal ingredients/treatments include clove oil, olive oil, or other treatments that are directly applied to the oral cavity for the treatment of oral health problems.
  • Participant who is currently taking a course of antibiotics or has taken a course of antibiotics within 2 weeks of baseline.
  • Participant who had dental procedures or participant who require antibiotic prophylaxis for dental procedures.
  • Any participant who, in the opinion of the investigator, should not participate in the study.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    Test Dentifrice

    Participants will be instructed to apply a full ribbon of test dentifrice to cover the head of the assigned toothbrush and brush twice daily for 1 timed minute throughout the 12-week treatment period.

    Drug: Test Dentifrice

  • Active comparator
    Comparator Dentifrice

    Participants will be instructed to apply a full ribbon of the comparator dentifrice to cover the head of the assigned toothbrush and brush twice daily for 1 timed minute throughout the 12-week treatment period.

    Drug: Colgate Sensitive ProRelief

  • Active comparator
    Negative Control Dentifrice

    Participants will be instructed to apply a full ribbon of the negative control dentifrice to cover the head of the assigned toothbrush and brush twice daily for 1 timed minute throughout the 12-week treatment period.

    Drug: Colgate Triple Protection

Interventions

  • DrugTest Dentifrice

    Dentifrice containing 1450 parts per million (ppm) fluoride as sodium monofluorophosphate.

  • DrugColgate Sensitive ProRelief

    A marketed dentifrice.

  • DrugColgate Triple Protection

    A marketed dentifrice.

06

What researchers measure

Primary outcomes

  1. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Week 12 (Test Dentifrice Versus [vs] Negative Control Dentifrice)

    Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0 equal to (=) no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoint.

    Time frame: Baseline and Week 12

Secondary outcomes

  1. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4 and 8 (Test Dentifrice vs Negative Control Dentifrice)

    Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, and 8

  2. Adjusted Mean Change From Baseline in Visual Analogue Scale (VAS) at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)

    Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 millimeter (mm) VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  3. Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)

    Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (grams \[g\]). Higher tactile threshold indicated a better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  4. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

    Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  5. Adjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

    Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 mm VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  6. Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

    Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (g). Higher tactile threshold indicated better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  7. Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

    Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  8. Adjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

    Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 mm VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

  9. Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

    Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (g). Higher tactile threshold indicated better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

    Time frame: Baseline, Weeks 2, 4, 8 and 12

07

Results

Posted May 13, 2026

Participant flow

This study was conducted at a single center in China.

Participant flow — Overall Study
MilestoneTest DentifriceComparator DentifriceNegative Control Dentifrice
Started424038
Completed424038
Not completed000

Outcome measures

PrimaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Week 12 (Test Dentifrice Versus [vs] Negative Control Dentifrice)

Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0 equal to (=) no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoint.

Time frame:
Baseline and Week 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Week 12 (Test Dentifrice Versus [vs] Negative Control Dentifrice)
score on a scaleTest DentifriceNegative Control Dentifrice
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Week 12 (Test Dentifrice Versus [vs] Negative Control Dentifrice)-1.19 ± 0.108-0.44 ± 0.084
Statistical analysis
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -0.75 · 95% CI -1.01 to -0.48
SecondaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4 and 8 (Test Dentifrice vs Negative Control Dentifrice)

Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, and 8
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4 and 8 (Test Dentifrice vs Negative Control Dentifrice)
score on a scaleTest DentifriceNegative Control Dentifrice
Week 2-0.44 ± 0.066-0.06 ± 0.057
Week 4-0.67 ± 0.081-0.20 ± 0.061
Week 8-0.92 ± 0.096-0.47 ± 0.072
Statistical analysis
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0001 · Adjusted mean difference: -0.38 · 95% CI -0.57 to -0.19
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -0.47 · 95% CI -0.69 to -0.26
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0006 · Adjusted mean difference: -0.45 · 95% CI -0.70 to -0.20
SecondaryAdjusted Mean Change From Baseline in Visual Analogue Scale (VAS) at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)

Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 millimeter (mm) VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Visual Analogue Scale (VAS) at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)
score on a scaleTest DentifriceNegative Control Dentifrice
Week 2-7.69 ± 2.149-6.74 ± 2.833
Week 4-12.99 ± 3.084-12.59 ± 2.748
Week 8-21.80 ± 3.236-16.81 ± 3.374
Week 12-29.21 ± 4.028-19.47 ± 3.917
Statistical analysis
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.7946 · Adjusted mean difference: -0.96 · 95% CI -8.23 to 6.31
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.9207 · Adjusted mean difference: -0.40 · 95% CI -8.31 to 7.52
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.2882 · Adjusted mean difference: -5.00 · 95% CI -14.28 to 4.28
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0600 · Adjusted mean difference: -9.74 · 95% CI -19.90 to 0.42
SecondaryAdjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)

Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (grams \[g\]). Higher tactile threshold indicated a better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · g
Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Negative Control Dentifrice)
gTest DentifriceNegative Control Dentifrice
Week 28.69 ± 1.8153.48 ± 1.065
Week 413.92 ± 2.8945.02 ± 1.843
Week 819.67 ± 2.7445.46 ± 1.709
Week 1231.64 ± 3.8707.76 ± 1.948
Statistical analysis
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0244 · Adjusted mean difference: 5.21 · 95% CI 0.69 to 9.73
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0093 · Adjusted mean difference: 8.91 · 95% CI 2.24 to 15.57
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: 14.21 · 95% CI 7.40 to 21.02
  • Test Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: 23.88 · 95% CI 14.50 to 33.26
SecondaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)
score on a scaleComparator DentifriceNegative Control Dentifrice
Week 2-0.69 ± 0.079-0.06 ± 0.057
Week 4-0.80 ± 0.084-0.20 ± 0.061
Week 8-1.10 ± 0.097-0.47 ± 0.072
Week 12-1.44 ± 0.093-0.44 ± 0.084
Statistical analysis
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -0.63 · 95% CI -0.82 to -0.43
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -0.61 · 95% CI -0.82 to -0.39
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -0.63 · 95% CI -0.89 to -0.38
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: -1.00 · 95% CI -1.26 to -0.73
SecondaryAdjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 mm VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)
score on a scaleComparator DentifriceNegative Control Dentifrice
Week 2-9.28 ± 3.053-6.74 ± 2.833
Week 4-14.40 ± 2.844-12.59 ± 2.748
Week 8-20.94 ± 3.687-16.81 ± 3.374
Week 12-28.79 ± 3.617-19.47 ± 3.917
Statistical analysis
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.4940 · Adjusted mean difference: -2.54 · 95% CI -9.87 to 4.79
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.6562 · Adjusted mean difference: -1.81 · 95% CI -9.84 to 6.22
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.3862 · Adjusted mean difference: -4.13 · 95% CI -13.53 to 5.27
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0759 · Adjusted mean difference: -9.32 · 95% CI -19.62 to 0.99
SecondaryAdjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)

Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (g). Higher tactile threshold indicated better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · g
Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Comparator Dentifrice vs Negative Control Dentifrice)
gComparator DentifriceNegative Control Dentifrice
Week 29.54 ± 1.7253.48 ± 1.065
Week 414.37 ± 2.2265.02 ± 1.843
Week 817.05 ± 2.5055.46 ± 1.709
Week 1228.54 ± 3.5737.76 ± 1.948
Statistical analysis
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0091 · Adjusted mean difference: 6.06 · 95% CI 1.54 to 10.59
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0067 · Adjusted mean difference: 9.35 · 95% CI 2.64 to 16.06
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = 0.0011 · Adjusted mean difference: 11.59 · 95% CI 4.73 to 18.46
  • Comparator Dentifrice vs Negative Control Dentifrice · ANCOVA · p = <0.0001 · Adjusted mean difference: 20.78 · 95% CI 11.33 to 30.23
SecondaryAdjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

Evaporative (air) sensitivity was evaluated using the Schiff Sensitivity Score on test teeth for each participant. After the examiner applied a standardized air stimulus, the participant's response was rated on a 0 to 3 scale, where 0= no response to the stimulus, 1= response to air stimulus without request for discontinuation of the stimulus, 2= response to air stimulus with request for discontinuation of the stimulus, and 3= a painful response with a request for discontinuation of the stimulus. Lower score indicated improvement. Change from Baseline was calculated by subtracting the Baseline score from the score at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in Schiff Sensitivity Score at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)
score on a scaleTest DentifriceComparator Dentifrice
Week 2-0.44 ± 0.066-0.69 ± 0.079
Week 4-0.67 ± 0.081-0.80 ± 0.084
Week 8-0.92 ± 0.096-1.10 ± 0.097
Week 12-1.19 ± 0.108-1.44 ± 0.093
Statistical analysis
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.0101 · Adjusted mean difference: 0.25 · 95% CI 0.06 to 0.43
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.2117 · Adjusted mean difference: 0.13 · 95% CI -0.08 to 0.34
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.1443 · Adjusted mean difference: 0.18 · 95% CI -0.06 to 0.43
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.0645 · Adjusted mean difference: 0.25 · 95% CI -0.02 to 0.51
SecondaryAdjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

Evaporative (air) sensitivity was assessed on the test teeth by applying a 1-second air stimulus from a standard dental syringe. Participants rated the intensity of their response to the evaporative (air) stimulus using a 100 mm VAS with scores ranging from 0 mm (No discomfort) to 100 mm (Extreme discomfort; worst imaginable). Higher score indicated worse outcome (higher sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · score on a scale
Adjusted Mean Change From Baseline in VAS at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)
score on a scaleTest DentifriceComparator Dentifrice
Week 2-7.69 ± 2.149-9.28 ± 3.053
Week 4-12.99 ± 3.084-14.40 ± 2.844
Week 8-21.80 ± 3.236-20.94 ± 3.687
Week 12-29.21 ± 4.028-28.79 ± 3.617
Statistical analysis
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.6635 · Adjusted mean difference: 1.58 · 95% CI -5.60 to 8.77
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.7215 · Adjusted mean difference: 1.41 · 95% CI -6.41 to 9.23
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.8504 · Adjusted mean difference: -0.87 · 95% CI -9.97 to 8.24
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.9332 · Adjusted mean difference: -0.43 · 95% CI -10.46 to 9.61
SecondaryAdjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)

Tactile sensitivity was assessed for eligible teeth using a constant pressure probe (Yeaple probe). After each application of the stimulus, participants were asked to indicate whether they experienced any pain or discomfort (yes/no response). The pressure setting with two consecutive 'yes' responses was recorded as the tactile threshold (g). Higher tactile threshold indicated better outcome (less sensitivity). Change from Baseline was calculated by subtracting Baseline value from the value at indicated timepoints.

Time frame:
Baseline, Weeks 2, 4, 8 and 12
Reported as:
Least squares mean · g
Adjusted Mean Change From Baseline in Tactile Threshold at Weeks 2, 4, 8 and 12 (Test Dentifrice vs Comparator Dentifrice)
gTest DentifriceComparator Dentifrice
Week 28.69 ± 1.8159.54 ± 1.725
Week 413.92 ± 2.89414.37 ± 2.226
Week 819.67 ± 2.74417.05 ± 2.505
Week 1231.64 ± 3.87028.54 ± 3.573
Statistical analysis
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.7023 · Adjusted mean difference: -0.86 · 95% CI -5.29 to 3.58
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.8935 · Adjusted mean difference: -0.44 · 95% CI -6.98 to 6.09
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.4369 · Adjusted mean difference: 2.62 · 95% CI -4.03 to 9.26
  • Test Dentifrice vs Comparator Dentifrice · ANCOVA · p = 0.5060 · Adjusted mean difference: 3.10 · 95% CI -6.10 to 12.30

Adverse events

Collected over Immediately from the start of the investigational product (or washout product), and until 5 days following last administration of the investigational product (Approximately up to 117 days).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Test Dentifrice0/42 (0%)0/42 (0%)2/42 (4.8%)
Comparator Dentifrice0/40 (0%)0/40 (0%)2/40 (5%)
Negative Control Dentifrice0/38 (0%)0/38 (0%)0/38 (0%)
Most frequent other events
Most frequent other events
EventTest DentifriceComparator DentifriceNegative Control Dentifrice
HypertensionVascular disorders0/421/400/38
NasopharyngitisInfections and infestations0/421/400/38
Mouth UlcerationGastrointestinal disorders1/420/400/38
PharyngitisInfections and infestations1/420/400/38

Baseline characteristics

Safety Population was defined as all participants who were randomised and administered at least one study treatment during the study.

Age, Continuous
Age, Continuous(years)Test DentifriceComparator DentifriceNegative Control DentifriceTotal
Mean40.4 ± 9.0640.8 ± 6.4939.1 ± 6.9540.1 ± 7.59
Sex: Female, Male
Sex: Female, Male(Participants)Test DentifriceComparator DentifriceNegative Control DentifriceTotal
Female373631104
Male54716
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Test DentifriceComparator DentifriceNegative Control DentifriceTotal
Hispanic or Latino0000
Not Hispanic or Latino424038120
Unknown or Not Reported0000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Test DentifriceComparator DentifriceNegative Control DentifriceTotal
Asian424038120
08

Study locations

1 site
  • School and Hospital of Stomatology, Wuhan University
    Wuhan, Hubei 430079, China
09

References and documents

Individual participant data

Plan to share: Yes — Anonymized individual participant data and study documents can be requested for further research from ww.clinical-trial-register@haleon.com.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: IPD will be made available within 6 months of publishing the results of the primary endpoints, key secondary endpoints and safety data of the study.

Access criteria: Access is provided after a research proposal is submitted and has received approval from the Independent Review Panel and after a Data Sharing Agreement is in place. Access is provided for an initial period of 12 months, but an extension can be granted, when justified, for up to another 12 months.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2013 to primary completion in Jun 2013, 4 months.

Results were first posted in May 2026, 12 years 11 months after primary completion.

Of 33 industry-sponsored interventional studies with no phase under Dentin Sensitivity, half reached primary completion within 3 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 6. This study's 4 months is above that.

Counting every sponsor, half of 144 studies reached it within 6 months; a quarter within 3 and three quarters within 10.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2025
First posted
Jan 5, 2026
StartActual
Jan 20, 2013
Primary completionActual
Jun 8, 2013
CompletionActual
Jun 8, 2013
Results first posted
May 13, 2026
Last update
May 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07317128
Lead sponsor
HALEON
Responsible party
Sponsor
First posted
Jan 5, 2026
Start date
Jan 20, 2013
Primary completion
Jun 8, 2013
Completion
Jun 8, 2013
Results posted
May 13, 2026
Last update
May 13, 2026

Study contacts

Minquan Du, DSS, PhD
principal investigator · Wuhan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion